T. Rowe Price Investment Management »

Bicara Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.3M 465k 15.79

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Becton Dickinson & Co Comm Stk (BDX)
Meta Platforms Comm Stk (META)
Yum Brands Comm Stk (YUM)
Abbott Labs Comm Stk (ABT)
Alphabet Comm Stk (GOOGL)
Centerpoint Energy Comm Stk (CNP)
Revvity Comm Stk (RVTY)
Nisource Comm Stk (NI)
Advanced Micro Devices Comm Stk (AMD)
Ameren Corp Comm Stk (AEE)

View all positions for T. Rowe Price Investment Management

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
Blackstone Group
Millennium Management
Geode Capital Management
Fil
Acorn Capital Advisors

View all funds holding Bicara Therapeutics